Google
 

Archive for the ‘Immune System / Vaccines’ Category

Researchers Close In On Possible Cause Of Autoimmune Liver Disease

Saturday, May 17th, 2008

A bacteria commonly found in soil and water triggered autoimmune symptoms in mice similar to those found in an incurable liver disease called Primary Biliary Cirrhosis (PBC). Reporting their findings in the May 15 Cell Host & Microbe, the multi-institutional research team said injecting laboratory mice with the bacterium - ...

New Data Support Routine Childhood Vaccination With PREVENAR In Europe - Shown To Reduce Invasive Pneumococcal Disease In Young Children

Saturday, May 17th, 2008

Data presented at the 26th annual meeting of the European Society for Paediatric Infectious Diseases (ESPID) in Graz, Austria, provide additional evidence of the public health impact of the routine use of Prevenar* (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed), which helps protect against the seven pneumococcal serotypes causing the majority of ...

More Vaccine-Autism Link Cases Heard By US Court

Thursday, May 15th, 2008

Parents claiming that the vaccine preservative thimerosal damaged their children's brains and led them to show symptoms of autism, brought their case before the United States Court of Federal Claims in Washington yesterday, Monday, the second case in a series of three where the court has to decide whether the ...

NIH Awards La Jolla Institute For Allergy & Immunology Major Grant To Test Safety Of New Smallpox Treatment

Thursday, May 15th, 2008

The La Jolla Institute for Allergy & Immunology (LIAI) has received a $7.1 million grant from the National Institutes of Health (NIH) to fund safety and effectiveness testing of an antibody treatment that quickly fights the smallpox virus. The treatment could be the nation's first line of defense in ...

Microbiologists Receive Top Canadian Recognition

Thursday, May 15th, 2008

One is a "veteran" researcher, the other "new", but two microbiologists from The University of Western Ontario have both been singled out to receive national recognition for their work on infectious diseases and immunity from the Canadian Society of Microbiologists (CSM).Dr. Miguel Valvano, a professor and Chair of the Department ...

Immunization Levels Among Inner City Children Enrolled In Subsidized Childcare Just Over Half Of National Averages, USA

Thursday, May 15th, 2008

The Centers for Disease Control and Prevention (CDC) conduct the National Immunization Survey to track rates of recommended immunization around the country. Since 2007, up-to-date (UTD) immunization of 2 year olds has held steady at about 82% of children nationally. Even of 19-35 month olds living in households below ...

GenVec Announces Grant For RSV Vaccine Program

Thursday, May 15th, 2008

GenVec, Inc. (Nasdaq:GNVC) announced that it has received an Advanced Technology Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases, of the National Institutes of Health, to support the Company's efforts to develop vaccines for the prevention of respiratory syncytial virus ...

Fungus Resistance At Molecular Level Keeps Tomatoes From Wilting

Thursday, May 15th, 2008

According to a study published in the open-access journal PLoSPathogens, researchers at the University of Amsterdam havediscovered how to conquer the wilting tomato. Dr. Martijn Repand colleagues reached their conclusions by studying the molecularlevel of the tomato.Plants pathogens are remarkably talented when it comes to evolvingalong with the immune systems ...

Novartis Menveo(R) Vaccine Shows Strong Immune Response Against Four Types Of Meningitis Disease In Pivotal Phase III Study

Thursday, May 15th, 2008

A vaccine being developed by Novartis against four types of meningitis produces a better antibody response than a commonly used existing vaccine, data released today shows. New Phase III data for Menveo® (MenACWY-CRM) show that the vaccine produced a greater immune response against meningococcal strains A, C, W-135 and Y ...

It’s The Virus, Stupid: Immune Exhaustion In HIV Infection

Thursday, May 15th, 2008

As HIV disease progresses in a person infected with the HIV virus, a group of cells in the immune system, the CD8+ T lymphocytes, become "exhausted," losing many of their abilities to kill other cells infected by the virus. For many years scientists have debated whether this ...

Researchers Attempting To Mimic The Way A Parasite Manipulates The Immune System

Sunday, April 13th, 2008

One day it may be possible to mimic the tactics used by parasites to trick the body into accepting transplanted tissues or organs.That is the hope of Dr Shane Grey from the Garvan Institute for Medical Research and Professor John Dalton from the Institute for the Biotechnology of Infectious Diseases ...

ECDC Warns Of Upsurge Of Measles In Europe: Unvaccinated People Are At Risk

Friday, April 11th, 2008

In 2007, several European countries experienced high numbers of measles cases, notably Switzerland, and to a lesser extent the United Kingdom (UK) and Romania (more than one case per 100,000 population per year). Full data for measles cases in Europe for 2007 can be found on the website of EUVAC.Net, ...

T-Cell Multiplication Unexpectedly Delayed After Infection

Friday, April 11th, 2008

In a surprising outcome that overturns the conventional wisdom on the body's immune response to infection, scientists at The Scripps Research Institute have shown that T cells do not begin proliferation until up to three days after infection.Until now, it was generally believed that memory T cells, lymphocytes that recognize ...

Mumps Resurged In United States

Thursday, April 10th, 2008

Despite the widespread use of a second dose of mumps vaccine in the US, the largest outbreak for two decades occurred in 2007, prompting calls for a more effective vaccine or changes in policy.Viral disease investigators from the US Centers for Disease Control and Prevention, and other colleagues from various ...

New Wesley Research Institute Study Aims To Halt The Progression Of Multiple Sclerosis

Wednesday, April 9th, 2008

A new research study being conducted at The Wesley Research Institute (WRI) aims to stop the progression of early active stage Multiple Sclerosis (MS) in its tracks.There are currently more than 2.5 million people worldwide with MS, a chronic disease that affects the central nervous system.They suffer from a ...